Version 2.78

Description


Vortioxetine is an antidepressant used to treat major depressive disorder (MDD). It binds to a variety of serotonin receptors and also inhibits the reuptake of serotonin, thereby increasing the amount of 5-HT in the synapse. Vortioxetine may also help reduce symptoms of anxiety. PMID: 25851751 
Vortioxetine takes about 2 weeks to reach steady-state concentration in the plasma, and it is primarily metabolized in the liver to an inactive metabolite. Side effects are primarily self-limited and include nausea, headache, and abdominal pain. PMID: 29920978 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Vortioxetine
Part Type
Component (Describes the core component or analyte measured)
Created On
2018-07-27
Construct for LOINC Short Name
Vortioxetine

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP268226-0
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP268226-0

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Vortioxetina
it-IT Italian (Italy) Vortioxetina
zh-CN Chinese (China) 沃替西汀
Synonyms: 伏硫西汀;Brintellix;心达悦;CAS 508233-74-7